期刊文献+

强化瑞舒伐他汀治疗冠脉慢血流患者的疗效及对颈动脉内膜厚度的影响

Influence of intensive rosuvastatin on the efficacy and carotid intimal thickness of patients with coronary slow flow
下载PDF
导出
摘要 目的探讨强化瑞舒伐他汀治疗冠脉慢血流(CSF)患者的疗效及对颈动脉内膜厚度的影响。方法将30例CSF患者随机分为两组(各15例),分别接受每日10 mg(A组)或20 mg(B组)瑞舒伐他汀治疗,疗程6个月,分析两组的治疗效果,记录心绞痛发作次数、持续时间,比较两组治疗前后的冠状动脉血流速度及颈动脉内膜厚度。结果两组的总有效率为100.0%,B组的显效率为73.3%,高于A组的53.3%(P<0.05);B组治疗后的心绞痛症状、冠状动脉血流速度及颈动脉内膜厚度均优于A组(P<0.05)。结论强化瑞舒伐他汀治疗CSF患者的效果较好,可有效改善心绞痛、冠状动脉血流速度及颈动脉内膜厚度。 Objective To explore the influence of intensive rosuvastatin on the efficacy and carotid intimal thickness of patients with coronary slow flow( CSF). Methods 30 patients with CSF were randomly assigned to receive 10 mg/d( n = 15,A group) or 20 mg/d( n = 15,B group) rosuvastatin for six months. The therapeutic effect of two groups was recorded. The incidence and duration of angina,coronary artery blood flow velocity and carotid intimal thickness were compared before and after treatment in both groups. Results The total effective rate was 100% in both groups,while obvious efficiency rate of B group was 73. 3%,higher than 53. 3%in A group( P〈0.05). Compared with A group,there were less incidence and duration of angina,higher coronary artery blood flow velocity and lower intimal thickness of carotid artery in B group( P〈0.05).Conclusions There is a better efficacy of intensive rosuvastatin on CSF patients,it can improve angina,coronary flow velocity and carotid intimal thickness.
出处 《齐齐哈尔医学院学报》 2016年第11期1462-1463,共2页 Journal of Qiqihar Medical University
基金 珠海市科信工贸局(编号:02657911140624049)
关键词 强化瑞舒伐他汀 冠脉慢血流 疗效 颈动脉内膜厚度 Rosuvastatin Coronary slow flow Efficacy Carotid intimal thickness
  • 相关文献

参考文献10

二级参考文献102

  • 1程训民,何国祥,仝识非,冉擘力,刘建平,姚青,宋治远.冠状动脉造影显示造影剂排空滞缓段的血管内超声研究[J].心肺血管病杂志,2005,24(4):193-195. 被引量:3
  • 2De Bruyne B, Hersbach F, Pijls NH, et al. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but "normal" coronary angiography. Circulation, 2001, 104 : 2401- 2406.
  • 3Beltrame ,IF, Limaye SB, Horowitz JD. The coronary slow flow phenomenon- a new coronary microvascular disorder. Cardiology, 2002, 97: 197-202.
  • 4Dimitrow PP. Transthoracic Doppler echocardiography-noninvasive diagnostic window for coronary flow reserve assessment. Cardiovasc Ultrasound, 2003, 1:4.
  • 5Erdogan D, Gullu H, Caliskan M, et al. Coronary flow reserve is preserved in white-coat hypertension. Heart, 2006, 92 : 1109- 1112.
  • 6Erdogan D, Caliskan M, Gullu H, et al. Coronary flow reserve is impaired in patients with slow coronary flow. Atherosclerosis, 2007, 191 : 168-174.
  • 7Beltrame JF, Limaye SB, Wuttle RD, et al. Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon. Am Heart J, 2003, 146: 84-90.
  • 8Camsari A, Ozcan T, Ozer C, et al. Carotid artery intima-media thichness correlates with intravascular ultrasound parameters in patients with slow coronary flow. Atherosclerosis, 2008, 200: 310-314.
  • 9Sezgin AT, Sigirci A, Barutcu I, et al. Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis, 2003, 14 : 155-161.
  • 10Caliskan M, Erdogan D, Gullu H, et al. Effects of atrovastatin on coronary flow reserve in patients with slow coronary flow. Clin Cardiol, 2007, 30: 475479.

共引文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部